
Strengthening Pharmacovigilance Systems for Safer Post-Market Drug Monitoring
Ensuring patient safety after a drug enters the market is one of the most critical responsibilities for pharmaceutical and biotechnology companies. Pharmacovigilance (PV) systems are designed to detect, assess, understand, and prevent adverse effects or any other drug-related problems. With increasing regulatory scrutiny and global market demands, companies must adopt








